ISIS PHARMACEUTICALS INC DEL's ticker is and the CUSIP is 464337AJ3. A total of 54 filers reported holding ISIS PHARMACEUTICALS INC DEL in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $319,000 | -7.3% | 313,000 | -1.6% | 0.02% | -13.8% |
| Q4 2020 | $344,000 | +5.5% | 318,000 | 0.0% | 0.03% | -3.3% |
| Q3 2020 | $326,000 | -96.8% | 318,000 | -96.5% | 0.03% | -97.1% |
| Q2 2020 | $10,064,000 | +7.0% | 9,116,000 | -2.8% | 1.03% | -7.6% |
| Q1 2020 | $9,408,000 | -16.8% | 9,376,000 | -4.5% | 1.12% | +4.3% |
| Q4 2019 | $11,314,000 | -40.7% | 9,821,000 | -41.2% | 1.07% | -46.2% |
| Q3 2019 | $19,084,000 | -6.4% | 16,707,000 | -3.0% | 1.99% | -12.7% |
| Q2 2019 | $20,380,000 | -13.0% | 17,232,000 | -0.9% | 2.28% | -20.6% |
| Q1 2019 | $23,415,000 | +24.1% | 17,382,000 | -1.4% | 2.87% | +4.7% |
| Q4 2018 | $18,871,000 | +1.2% | 17,622,000 | -0.5% | 2.74% | +6.4% |
| Q3 2018 | $18,640,000 | +9.5% | 17,717,000 | +1.9% | 2.58% | -1.9% |
| Q2 2018 | $17,016,000 | -99.9% | 17,387,000 | +0.5% | 2.62% | -3.5% |
| Q1 2018 | $17,094,989,000 | -4.8% | 17,307,000 | +2.4% | 2.72% | -5.8% |
| Q4 2017 | $17,953,205,000 | +0.0% | 16,907,000 | -0.2% | 2.89% | -7.3% |
| Q3 2017 | $17,946,697,000 | -0.5% | 16,935,000 | +0.4% | 3.12% | -8.5% |
| Q2 2017 | $18,043,256,000 | +12.5% | 16,875,000 | +1.6% | 3.41% | +9.4% |
| Q1 2017 | $16,031,647,000 | -4.0% | 16,615,000 | +1.2% | 3.11% | -9.8% |
| Q4 2016 | $16,707,513,000 | +15.3% | 16,410,000 | +5.5% | 3.45% | +13.8% |
| Q3 2016 | $14,486,691,000 | -30.0% | 15,550,000 | -47.0% | 3.04% | -36.1% |
| Q2 2016 | $20,706,980,000 | +61.9% | 29,330,000 | +117.5% | 4.75% | +54.4% |
| Q1 2016 | $12,793,894,000 | – | 13,485,000 | – | 3.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|